Impulsivity and its Therapeutic Management in Borderline Personality Disorder: a Systematic Review.


Journal

The Psychiatric quarterly
ISSN: 1573-6709
Titre abrégé: Psychiatr Q
Pays: United States
ID NLM: 0376465

Informations de publication

Date de publication:
12 2020
Historique:
accepted: 17 09 2020
pubmed: 30 9 2020
medline: 9 11 2021
entrez: 29 9 2020
Statut: ppublish

Résumé

No treatment has been approved and recognized as effective in borderline personality disorder (BPD). Impulsivity is a key dimension because it is a predictor of remission but also suicide. The purpose of this review is to establish an inventory on the management of impulsivity in BPD and determine the effective treatments. A systematic review on the PubMed and Ovid databases was conducted up to September 2019 to December 2019 using the PRISMA guidelines. The inclusion criteria were: studies with patients with borderline personality disorder, were published between 1989 and 2019, used English-language and evaluated impulsivity before and after treatment. 41 articles selected were included for pharmacological treatment. 24 articles were found for psychotherapeutic management and one randomized study of transcranial magnetic stimulation. Based on this review, we must focus on psychotherapy in BPD, particularly the schema therapy, dialectical behavioral therapy, psychoeducation, system training of emotional predictability and problem solving and psychotherapy using mentalisation. The use of neuroleptics and mood stabilizers appears to be more effective than antidepressants. Another approach, such as transcranial magnetic stimulation, may prove useful in the near future if this technique is studied further.

Identifiants

pubmed: 32989635
doi: 10.1007/s11126-020-09845-z
pii: 10.1007/s11126-020-09845-z
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1333-1362

Auteurs

Anaïs Mungo (A)

Erasme Hospital, Department of Psychiatry and Sleep Laboratory, Université libre de Bruxelles, Route de Lennik, 808-1070, Anderlecht, Belgium. SecMed.Psy@erasme.ulb.ac.be.

Matthieu Hein (M)

Erasme Hospital, Department of Psychiatry and Sleep Laboratory, Université libre de Bruxelles, Route de Lennik, 808-1070, Anderlecht, Belgium.

Philippe Hubain (P)

Erasme Hospital, Department of Psychiatry and Sleep Laboratory, Université libre de Bruxelles, Route de Lennik, 808-1070, Anderlecht, Belgium.

Gwenolé Loas (G)

Erasme Hospital, Department of Psychiatry and Sleep Laboratory, Université libre de Bruxelles, Route de Lennik, 808-1070, Anderlecht, Belgium.

Philippe Fontaine (P)

Department of Psychiatry, CHC Liège - site Saint Vincent, Rocourt, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH